Back

Prevalence of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: the RETTRACE study

31 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Cardiac amyloidosis (3) Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Dimitrios Tsilakis

Athens (Greece)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor D. Faro (Catania, IT)
Abstract Video
Presentation thumbnail
Doctor M. Dicorato (Bari, IT)
Abstract Video
Presentation thumbnail
Doctor I. Simkova (Olomouc, CZ)
Abstract
Presentation thumbnail
Doctor S. Yoshida (Kanazawa, JP)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Cardiac amyloidosis (3)

The Event

Event poster

ESC Congress 2025

31 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Multimodality imaging and genetic assessment in the diagnosis of amyloid cardiomyopathy
thumbnail
Congress Presentation
Differentiating transthyretin cardiac amyloidosis among left ventricular hypertrophy phenotypes: the role of right and left ventricular global longitudinal strain
thumbnail
Congress Presentation
Current practices and access to cardiac bone scans for the detection of transthyretin cardiac amyloidosis based on the results of a large national electronic survey

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources